首页> 中文期刊>中国医药指南 >不同剂量的纳络酮治疗早期高血压脑出血的临床研究

不同剂量的纳络酮治疗早期高血压脑出血的临床研究

     

摘要

目的探究不同剂量的纳络酮治疗早期高血压脑出血的临床效果。方法回顾性分析86例早期高血压脑出血患者的临床资料,分成观察组和对照组患者各43例。在常规治疗的基础上,观察组进行大剂量纳洛酮(7 mg/d)进行治疗,对照组进行常规剂量(3 mg/d)的治疗,对比分析两组患者的脑水肿、颅内压变化和意识障碍恢复时间的情况。结果观察组患者的治疗效果较好(P<0.05)。结论与常规剂量治疗的方法相比,大剂量使用纳洛酮更有利于患者的疾病治疗情况。%Objective To explore the different doses of naloxone in the treatment of hypertensive cerebral hemorrhage early clinical results. Methods A retrospective analysis of 86 cases of hypertensive cerebral hemorrhage early clinical data , divided into observation group and control group of 43 cases. In the conventional treatment, based on the observation group, high-dose naloxone (7 mg/d) for the treatment and control group routine dose (3 mg/d) treatment, comparative analysis of the two groups of patients with cerebral edema, intracranial pressure changes and consciousness recovery time situation. Results The treatment of patients with better (P<0.05). Conclusion Compared with conventional dose therapy methods, high doses of naloxone is more conducive to the patient's disease treatment.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号